loading

Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten

pulisher
08:27 AM

Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest[i] Parasite Protection of Its Kind - The Eastern Progress Online

08:27 AM
pulisher
03:50 AM

Assenagon Asset Management S.A. Has $2.16 Million Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

03:50 AM
pulisher
Jan 22, 2025

Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc. - Benzinga

Jan 22, 2025
pulisher
Jan 21, 2025

UK Veterinary Medicine Market May See a Big Move | Norbrook, Merck, Elanco - openPR

Jan 21, 2025
pulisher
Jan 21, 2025

Is Elanco Animal Health Incorporated (ELAN) the Most Undervalued Stock to Invest in for Under $20? - Insider Monkey

Jan 21, 2025
pulisher
Jan 20, 2025

12 Most Undervalued Stocks to Invest in for Under $20 - Insider Monkey

Jan 20, 2025
pulisher
Jan 19, 2025

2025-01-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 19, 2025
pulisher
Jan 18, 2025

ELAN (Elanco Animal Health) Deferred Tax : $0 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 18, 2025
pulisher
Jan 18, 2025

US FDA approves Elanco's treatment for parasitic infections in dogs - AOL

Jan 18, 2025
pulisher
Jan 17, 2025

Elanco Animal Health's SWOT analysis: stock outlook amid product challenges - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

ELAN (Elanco Animal Health) Long-Term Debt : $4,313 Mil (As of Sep. 2024) - GuruFocus.com

Jan 17, 2025
pulisher
Jan 16, 2025

Elanco Animal Health’s SWOT analysis: stock outlook amid product challenges - Investing.com Nigeria

Jan 16, 2025
pulisher
Jan 16, 2025

Companion Animal Ear Infection Treatment Market SWOT Analysis by Leading Expert: Elanco, Vetoquinol, Ceva - openPR

Jan 16, 2025
pulisher
Jan 15, 2025

2025-01-15 | Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 15, 2025
pulisher
Jan 15, 2025

Elanco Animal Health: Building On Success (NYSE:ELAN) - Seeking Alpha

Jan 15, 2025
pulisher
Jan 15, 2025

Veterinary Vaccines Market SWOT Analysis by Leading Expert: Virbac, Elanco, HIPRA - openPR

Jan 15, 2025
pulisher
Jan 14, 2025

ELAN (Elanco Animal Health) Change In Working Capital : $239 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 14, 2025
pulisher
Jan 12, 2025

2025-01-12 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 12, 2025
pulisher
Jan 12, 2025

Is Elanco Animal Health (ELAN) the Best Medical Stock to Buy Under $20? - Insider Monkey

Jan 12, 2025
pulisher
Jan 11, 2025

12 Best Medical Stocks To Buy Under $20 - Insider Monkey

Jan 11, 2025
pulisher
Jan 10, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Stock Position Increased by Harbor Capital Advisors Inc. - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Elanco Animal Health (FRA:5EA) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Jan. 10, 2025) - GuruFocus.com

Jan 10, 2025
pulisher
Jan 10, 2025

Elanco Animal Health (FRA:5EA) Gross Profit : €2,236 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 10, 2025
pulisher
Jan 10, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Receives $16.43 Average Target Price from Brokerages - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of “Hold” from Analysts - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

Animal Health Business Research Report 2024-2030 Featuring Major PlayersBayer, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Heska, Merck, Nutreco, Vetiquinol, Virbac, and Zoetis - Yahoo Finance

Jan 09, 2025
pulisher
Jan 09, 2025

17,250 Shares in Elanco Animal Health Incorporated (NYSE:ELAN) Purchased by Everence Capital Management Inc. - Defense World

Jan 09, 2025
pulisher
Jan 09, 2025

Elanco Animal Health (NYSE:ELAN) Reaches New 52-Week Low on Analyst Downgrade - Defense World

Jan 09, 2025
pulisher
Jan 09, 2025

Elanco Animal Health (FRA:5EA) Other Long Term Assets : €272 Mil (As of Sep. 2024) - GuruFocus.com

Jan 09, 2025
pulisher
Jan 08, 2025

Douglas Lane & Associates LLC Trims Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

Growth Trends in the Porcine Vaccines Market, Forecast to 2028: Increasing Government Initiatives for Funding Animal Husbandry - GlobeNewswire Inc.

Jan 08, 2025
pulisher
Jan 08, 2025

Elanco Animal Health (NYSE:ELAN) Sets New 1-Year Low on Analyst Downgrade - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

2025-01-08 | Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 08, 2025
pulisher
Jan 08, 2025

Elanco Animal Health (NYSE:ELAN) Takes On Some Risk With Its Use Of Debt - Simply Wall St

Jan 08, 2025
pulisher
Jan 08, 2025

Versant Capital Management Inc Sells 1,241 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Jan 08, 2025
pulisher
Jan 07, 2025

Stifel Nicolaus Lowers Elanco Animal Health (NYSE:ELAN) Price Target to $18.00 - MarketBeat

Jan 07, 2025
pulisher
Jan 07, 2025

Veterinary Oncology Market Generated Opportunities, Future - openPR

Jan 07, 2025
pulisher
Jan 06, 2025

Principal Financial Group Inc. Sells 21,919 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Jan 06, 2025
pulisher
Jan 05, 2025

2025-01-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 05, 2025
pulisher
Jan 01, 2025

JPMorgan Chase & Co. Increases Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jan 01, 2025
$95.33
price up icon 0.58%
$30.20
price down icon 0.13%
$11.21
price up icon 0.63%
$127.27
price up icon 0.62%
$147.00
price down icon 0.14%
Kapitalisierung:     |  Volumen (24h):